title: MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells.
abstract: MicroRNAs (miRNAs) and DNA mismatch repair (MMR) have been linked to human cancer progression. Human mutL homolog 1 (hMLH1), one of the core MMR genes, defects in lung cancer development. However, the interaction between miRNAs and MMR genes and their regulatory effect on cell cycle remain poorly understood. In this study, we investigated the role of miR-31-5p in hMLH1 gene expression and the effect of miR-31-5p on cell cycle in non-small cell lung cancer (NSCLC). We found that miR-31-5p was inversely correlated with hMLH1 expression in NSCLC cell lines and hMLH1 was a direct target of miR-31-5p. Knockdown of miR-31-5p induced a cell cycle arrest at G2/M phase and increased hMLH1 protein expression in NSCLC cells. Conversely, overexpression of miR-31-5p significantly induced cell cycle arrest at S phase and decreased hMLH1 protein expression. Furthermore, knockdown of hMLH1 upregulated miR-31-5p expression and caused cell cycle arrest at S phase. Data from this study revealed that miR-31-5p modulates cell cycle by targeting hMLH1 protein at the posttranscriptional level in NSCLC, which may represent a novel therapy strategy for lung cancer by targeting miR-31-5p.
authors.affiliation: Institute of Biochemistry and Molecular Biology, School of Medicine, Ningbo University, 818 Fenghua Road, Ningbo, China.
authors.forename: Zhiwei
authors.initials: Z
authors.lastname: Zhong
authors.forename: Zhuo
authors.initials: Z
authors.lastname: Dong
authors.forename: Lihua
authors.initials: L
authors.lastname: Yang
authors.forename: Xiaoqiang
authors.initials: X
authors.lastname: Chen
authors.forename: Zhaohui
authors.initials: Z
authors.lastname: Gong
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D015153:Blotting, Western; D018287:Carcinoma, Large Cell / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002453:Cell Cycle / Q000502:physiology*; D005434:Flow Cytometry; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D008175:Lung Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D035683:MicroRNAs / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D000070957:MutL Protein Homolog 1; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C534612:MIRN31 microRNA, human; C501486:MLH1 protein, human; D035683:MicroRNAs; D009687:Nuclear Proteins; D012333:RNA, Messenger; D008156:Luciferases; D000070957:MutL Protein Homolog 1
references.citation: J Clin Oncol. 2009 Dec 1;27(34):5848-56
references.pmid: 19884536
references.citation: J Cancer Res Clin Oncol. 2012 Oct;138(10):1781-8
references.pmid: 22806311
references.citation: Int J Cancer. 2010 Mar 1;126(5):1166-76
references.pmid: 19676045
references.citation: Cell Cycle. 2010 Nov 1;9(21):4387-98
references.pmid: 20980827
references.citation: Int J Oncol. 2009 Apr;34(4):1069-75
references.pmid: 19287964
references.citation: Nat Rev Clin Oncol. 2010 Apr;7(4):197-208
references.pmid: 20177404
references.citation: Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1950-4
references.pmid: 7892206
references.citation: BMC Cancer. 2010 Nov 09;10:616
references.pmid: 21062447
references.citation: J Biol Chem. 2010 Oct 22;285(43):33010-33017
references.pmid: 20709753
references.citation: Med Oncol. 2010 Sep;27(3):685-9
references.pmid: 19598010
references.citation: Cell. 2009 Jun 12;137(6):1032-46
references.pmid: 19524507
references.citation: J Mol Med (Berl). 2012 Dec;90(12):1449-58
references.pmid: 22706599
references.citation: FASEB J. 2010 Oct;24(10):3869-81
references.pmid: 20522784
references.citation: Cell Res. 2012 Jun;22(6):973-85
references.pmid: 22290424
references.citation: Cancer Res. 2001 Jul 1;61(13):5193-201
references.pmid: 11431359
references.citation: BMB Rep. 2010 Apr;43(4):291-6
references.pmid: 20423616
references.citation: Cancer Res. 2010 Mar 1;70(5):1906-15
references.pmid: 20179198
references.citation: Mol Cell Biochem. 2011 Sep;355(1-2):257-63
references.pmid: 21553022
references.citation: Lung Cancer. 2009 Jun;64(3):282-8
references.pmid: 19056144
references.citation: J Surg Oncol. 2008 Oct 1;98(5):377-83
references.pmid: 18646042
references.citation: Urol Oncol. 2011 Nov-Dec;29(6):794-801.e1
references.pmid: 19945312
references.citation: Nat Rev Genet. 2010 Sep;11(9):597-610
references.pmid: 20661255
references.citation: Oncogene. 2013 Jan 17;32(3):341-51
references.pmid: 22370637
references.citation: Cell Res. 2008 Jan;18(1):85-98
references.pmid: 18157157
references.citation: Front Genet. 2012 Jan 23;2:104
references.pmid: 22303398
references.citation: J Clin Invest. 2010 Apr;120(4):1298-309
references.pmid: 20237410
references.citation: Cancer Res. 2010 Feb 15;70(4):1635-44
references.pmid: 20145132
references.citation: Gastroenterology. 2008 Jul;135(1):257-69
references.pmid: 18555017
references.citation: PLoS One. 2012;7(6):e38648
references.pmid: 22719913
references.citation: Clin Cancer Res. 2008 May 1;14(9):2588-92
references.pmid: 18451220
references.citation: Cancer Res. 1999 Feb 1;59(3):538-41
references.pmid: 9973196
references.citation: Science. 2011 Dec 23;334(6063):1713-6
references.pmid: 22194578